National Health Investors (NHI) Receives Hold Rating from Cantor Fitzgerald
National Health Investors (NYSE:NHI)‘s stock had its “hold” rating reaffirmed by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Wednesday. They presently have a $85.00 price objective on the real estate investment trust’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 19.65% from the company’s previous close.
Several other analysts have also issued reports on the company. Zacks Investment Research lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, November 17th. Capital One Financial initiated coverage on National Health Investors in a report on Monday, October 23rd. They set an “equal weight” rating for the company. KeyCorp restated an “underweight” rating on shares of National Health Investors in a report on Tuesday, December 19th. ValuEngine upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Friday, November 10th. Finally, Stifel Nicolaus restated a “buy” rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $81.25.
Shares of National Health Investors (NYSE NHI) traded up $0.98 during trading hours on Wednesday, hitting $71.04. The company had a trading volume of 258,500 shares, compared to its average volume of 249,527. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a twelve month low of $68.96 and a twelve month high of $81.60. The stock has a market capitalization of $2,909.74, a price-to-earnings ratio of 17.76, a price-to-earnings-growth ratio of 3.31 and a beta of 0.59.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Jacobi Capital Management LLC raised its holdings in National Health Investors by 187.7% during the third quarter. Jacobi Capital Management LLC now owns 1,827 shares of the real estate investment trust’s stock valued at $142,000 after buying an additional 1,192 shares in the last quarter. Fortaleza Asset Management Inc. raised its holdings in National Health Investors by 123.7% during the third quarter. Fortaleza Asset Management Inc. now owns 2,740 shares of the real estate investment trust’s stock valued at $212,000 after buying an additional 1,515 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in National Health Investors during the third quarter valued at about $237,000. Profund Advisors LLC raised its holdings in National Health Investors by 4.3% during the second quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock valued at $248,000 after buying an additional 130 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new position in National Health Investors during the third quarter valued at about $249,000. Institutional investors own 70.52% of the company’s stock.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.